As MYH9 is functionally associated with sunitinib tolerance in ccRCC cells, we further explored whether MYH9 expression in tumor tissues was involved in the response of patients to sunitinib therapy. This evidence concerns the gene MYH9 and nonpapillary renal cell carcinoma.